Beijing Hotgen Biotech Co., Ltd.

Location

Beijing

Founded

2005-10-23

Website

http://www.hotgen.com.cn

Risk Signals

7 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., In Vitro and In Vivo Diagnostic Substances), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Stock Market Events (2) Financial Reporting (1) Investor Activism (1) Issuing Shares (1) Market Trends (1) Public Health Crisis Response (1)

Recent Articles about Beijing Hotgen Biotech Co., Ltd.

Live alerts from global media, monitored by Business Radar

Stock Market news : Wuhan Golden Laser Leads Gainers with 20.03% Rise; Beijing Hotgen Biotech Drops 9.59%

2024-11-22 (businessupturn.com)

Stock Market news : Wuhan Golden Laser Leads Gainers with 20.03% Rise; Beijing Hotgen Biotech Drops 9.59%

Wuhan Golden Laser surged 20.03% to 14.92 CNY, topping the gainers, while Beijing Hotgen Biotech led losses, declining 9.59% to 45.84 CNY amid mixed market performance.

Read more

Never miss a headline about Beijing Hotgen Biotech Co., Ltd.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages